These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26117980)

  • 21. Overweight, obesity and hyperandrogenemia are associated with gestational diabetes mellitus: A follow-up cohort study.
    West S; Ollila MM; Franks S; Piltonen T; Jokelainen J; Nevalainen J; Puukka K; Ruokonen A; Järvelin MR; Auvinen J; Tapanainen JS; Morin-Papunen L
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1311-1319. PubMed ID: 32333801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Group-based developmental BMI trajectories, polycystic ovary syndrome, and gestational diabetes: a community-based longitudinal study.
    Kakoly NS; Earnest A; Moran LJ; Teede HJ; Joham AE
    BMC Med; 2017 Nov; 15(1):195. PubMed ID: 29110650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological markers of autoimmunity in pregnant women with polycystic ovary syndrome: a pilot study.
    Pérez-Bravo F; Carrasco E; Echiburú B; Maliqueo M; Diaz J; Sir-Petermann T
    Gynecol Endocrinol; 2010 Dec; 26(12):889-93. PubMed ID: 20504101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pregnancy outcomes in women with gestational diabetes: specific subgroups might require increased attention].
    Bartáková V; Ťápalová V; Wágnerová K; Janků P; Bělobrádková J; Kaňková K
    Ceska Gynekol; 2017; 82(1):16-23. PubMed ID: 28252306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome.
    Pirotta S; Joham A; Grieger JA; Tay CT; Bahri-Khomami M; Lujan M; Lim SS; Moran LJ
    Semin Reprod Med; 2020 Nov; 38(6):342-351. PubMed ID: 33873233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish cohort study.
    Palm CVB; Glintborg D; Kyhl HB; McIntyre HD; Jensen RC; Jensen TK; Jensen DM; Andersen M
    Diabetes Res Clin Pract; 2018 Nov; 145():167-177. PubMed ID: 29689322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of maternal obesity in infant outcomes in polycystic ovary syndrome-A systematic review, meta-analysis, and meta-regression.
    Bahri Khomami M; Joham AE; Boyle JA; Piltonen T; Arora C; Silagy M; Misso ML; Teede HJ; Moran LJ
    Obes Rev; 2019 Jun; 20(6):842-858. PubMed ID: 30785659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study.
    Bond R; Pace R; Rahme E; Dasgupta K
    Diabet Med; 2017 Dec; 34(12):1684-1695. PubMed ID: 28782842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
    Li Y; Ruan X; Wang H; Li X; Cai G; Du J; Wang L; Zhao Y; Mueck AO
    Fertil Steril; 2018 Apr; 109(4):720-727. PubMed ID: 29525688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of antenatal clinical factors for prediction of postpartum outcomes in women with gestational diabetes mellitus (GDM).
    Ingram ER; Robertson IK; Ogden KJ; Dennis AE; Campbell JE; Corbould AM
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):272-279. PubMed ID: 27549600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of polycystic ovaries in women with a history of gestational diabetes.
    Kousta E; Cela E; Lawrence N; Penny A; Millauer B; White D; Wilson H; Robinson S; Johnston D; McCarthy M; Franks S
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):501-7. PubMed ID: 11012576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA; Requena A; Salvador C; Tur R; Callejo J; Espinós JJ; Fábregues F; Herrero J;
    Hum Reprod Update; 2005; 11(4):375-90. PubMed ID: 15878899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes.
    Hocaoglu M; Demirer S; Loclar Karaalp I; Kaynak E; Attar E; Turgut A; Karateke A; Komurcu-Bayrak E
    Gynecol Endocrinol; 2021 Mar; 37(3):216-220. PubMed ID: 33148068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome.
    Bjercke S; Dale PO; Tanbo T; Storeng R; Ertzeid G; Abyholm T
    Gynecol Obstet Invest; 2002; 54(2):94-8. PubMed ID: 12566751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes?
    Alshammari A; Hanley A; Ni A; Tomlinson G; Feig DS
    J Matern Fetal Neonatal Med; 2010 Jun; 23(6):545-9. PubMed ID: 19718584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome.
    Weerakiet S; Srisombut C; Rojanasakul A; Panburana P; Thakkinstian A; Herabutya Y
    Gynecol Endocrinol; 2004 Sep; 19(3):134-40. PubMed ID: 15697074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome.
    Selen DJ; Powe CE
    Curr Opin Endocrinol Diabetes Obes; 2022 Dec; 29(6):521-527. PubMed ID: 35983844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Gestational Diabetes Mellitus in Chinese Women with Polycystic Ovary Syndrome: A Cross-Sectional Study.
    Zhang YJ; Jin H; Qin ZL; Ma JL; Zhao H; Zhang L; Chen ZJ
    Gynecol Obstet Invest; 2016; 81(3):220-4. PubMed ID: 26461523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.